What Is CAH Fair Value?
Cardinal Health (CAH) fair value estimate using multiple valuation models, updated daily.
As of July 16, 2026, Cardinal Health (CAH) has a composite fair value estimate of $1,151.02 based on four valuation models: DCF (47% weight), Graham Number (0% weight), PEG (33% weight), and DDM (20% weight). The current market price is $224.94, suggesting the stock is undervalued by 411.7%.
Data as of July 16, 2026 (today)
Composite Fair Value
Undervalued3 of 4 models$1,151.02
vs. current price of $224.94(+411.7%)
How Is CAH Fair Value Calculated?
Four independent models estimate what CAH is worth. Each uses different inputs and assumptions. The composite blends them by weight.
CAH Intrinsic Value
Forward-looking models based on future cash flows
DCF (Discounted Cash Flow)
47% weightEstimates how much cash the company will generate over the next 10 years, then calculates what all that future cash is worth in today's dollars. Includes a 15% safety cushion. Try the standalone DCF calculator →
$1,878.39
+735.1%Undervalued
Inputs used
DDM (Dividend Discount Model)
20% weightIf a company pays you dividends, this model asks: how much are all those future dividend payments worth today? Only works for stocks that pay dividends. Try the intrinsic value calculator →
$217.73
-3.2%Fair Value
Inputs used
CAH Fair Value
Current fundamentals: earnings, assets, and growth rate
Graham Number (Value Investing)
0% weightCreated by legendary investor Benjamin Graham. It looks at two things: how much the company earns (EPS) and what its assets are worth (Book Value), then calculates the maximum price a careful investor should pay. Try the fair value calculator →
N/A
Requires positive EPS and book value. Cardinal Health currently has negative earnings, so the Graham formula cannot be applied.
Inputs used
PEG (Price/Earnings to Growth)
33% weightChecks if you're paying a fair price for the company's growth. A fast-growing company deserves a higher price than a slow one. This model finds the right price based on how fast earnings are growing.
$228.60
+1.6%Fair Value
Inputs used
What If You Change the Assumptions?
Drag the sliders to test different scenarios. Tap the ? buttons to learn what each input means.
Your DCF Fair Value
Current price $224.94 is 735.1% below this estimate
View 10-year cash flow projections
| Year | Projected FCF (Free Cash Flow) | Present Value |
|---|---|---|
| Year 1 | $5.88B | $5.51B |
| Year 2 | $7.13B | $6.25B |
| Year 3 | $8.64B | $7.10B |
| Year 4 | $10.47B | $8.07B |
| Year 5 | $12.69B | $9.16B |
| Year 6 | $15.38B | $10.40B |
| Year 7 | $18.65B | $11.81B |
| Year 8 | $22.60B | $13.42B |
| Year 9 | $27.40B | $15.23B |
| Year 10 | $33.21B | $17.30B |
| Terminal Value | $803.01B | $418.29B |
What Are CAH's Key Financial Metrics?
Earnings & Growth
Current Price
$224.94
EPS (TTM)
$6.41
Forward P/E
18.7
Profit Margin
0.6%
Cash & Balance Sheet
Free Cash Flow
4.8B
EBITDA
4B
Book Value
-$12.05
Total Debt
8.9B
What Do Analysts Say About CAH?
Low
$215.00
Average
$249.60
High
$275.00
Upside
+11.0%
CAH Fair Value FAQ
What is the fair value of CAH?
Based on our composite model (DCF 35%, Graham 25%, PEG 25%, DDM 15%), CAH's estimated fair value is $1,151.02. The stock is currently trading at $224.94, which makes it undervalued by our analysis.
How is CAH's fair value calculated?
We use four valuation methods: Discounted Cash Flow (DCF), Graham Number, PEG-based Fair Value, and Dividend Discount Model (for dividend-paying stocks). The composite score weights DCF at 35%, Graham and PEG at 25% each, and DDM at 15%. When a model can't be applied, its weight is redistributed proportionally.
Is CAH overvalued or undervalued?
Based on our analysis, CAH is undervalued. The current price of $224.94 is 411.7% below our estimated fair value of $1,151.02.
What do Wall Street analysts say about CAH?
15 analysts cover Cardinal Health with a consensus rating of "Strong Buy." The average price target is $249.60, ranging from $215.00 to $275.00. This implies 11.0% upside from the current price.